Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002053.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 14.60 1.73 1.51
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -43.52 12.47 22.07
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 5.25 7.86 7.47
Cash -0.01 2.65 2.65
Capex 57.78 -0.48 -1.13
Free Cash Flow 81.16 -0.14 -0.73
Revenue 3.85 1.04 1.01
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 34.01 0.54 0.40
Operating Margin 213.48 0.41 0.13
ROA 131.33 0.02 < 0.005
ROE 124.70 0.05 0.02
ROIC 254.29 0.02 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002053.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002053.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002053.SZ is permitted for members.